Clinician-led approach could give doctors a control dial for cell therapies
An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.